![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 8, 5472-5477, February 25, 2000
From the Heat shock protein (HSP)-peptide complexes from
tumor cells elicit specific protective immunity when injected into
inbred mice bearing the same specific type of tumor. The HSP-mediated specific immunogenicity also occurs with virus-infected cells. The
immune response is solely due to endogenous peptides noncovalently bound to HSP. A vesicular stomatitis virus capsid-derived peptide ligand bearing a photoreactive azido group was specifically bound by
and cross-linked to murine HSP glycoprotein (gp) 96. The
peptide-binding site was mapped by specific proteolysis of the
cross-links followed by analysis of the cross-linked peptides using a
judicious combination of SDS-gel electrophoresis, mass spectrometry,
and amino acid sequencing. The minimal peptide-binding site was mapped
to amino acid residues 624-630 in a highly conserved region of gp96. A model of the peptide binding pocket of gp96 was constructed based on
the known crystallographic structure of major histocompatibility complex class I molecule bound to a similar peptide. The gp96-peptide model predicts that the peptide ligand is held in a groove formed by
Identification of the Peptide-binding Site in the Heat Shock
Chaperone/Tumor Rejection Antigen gp96 (Grp94)*
,
¶
Laboratory of Molecular Genetics, Box 174, and § Computing Services, The Rockefeller University,
New York, New York 10021
-helices and lies on a surface consisting of antiparallel
-sheets. Interestingly, in this model, the peptide binding pocket abuts the dimerization domain of gp96, which may have implications for
the extraordinary stability of peptide-gp96 complexes, and for the
faithful relay of peptides to major histocompatibility complex class I
molecule for antigen presentation.
*
This work was supported by a research grant from Antigenics
L.L.C. New York.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
R. J. Binder, J. B. Kelly III, R. E. Vatner, and P. K. Srivastava Specific Immunogenicity of Heat Shock Protein gp96 Derives from Chaperoned Antigenic Peptides and Not from Contaminating Proteins J. Immunol., December 1, 2007; 179(11): 7254 - 7261. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Javid, P. A. MacAry, and P. J. Lehner Structure and Function: Heat Shock Proteins and Adaptive Immunity J. Immunol., August 15, 2007; 179(4): 2035 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Wang, H. Arnouk, X. Chen, L. Kazim, E. A. Repasky, and J. R. Subjeck Extracellular Targeting of Endoplasmic Reticulum Chaperone Glucose-Regulated Protein 170 Enhances Tumor Immunity to a Poorly Immunogenic Melanoma J. Immunol., August 1, 2006; 177(3): 1543 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Biswas, U. Sriram, B. Ciric, O. Ostrovsky, S. Gallucci, and Y. Argon The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells Int. Immunol., July 1, 2006; 18(7): 1147 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Demine and P. Walden Testing the Role of gp96 as Peptide Chaperone in Antigen Processing J. Biol. Chem., May 6, 2005; 280(18): 17573 - 17578. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Korbelik, J. Sun, and I. Cecic Photodynamic Therapy-Induced Cell Surface Expression and Release of Heat Shock Proteins: Relevance for Tumor Response Cancer Res., February 1, 2005; 65(3): 1018 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, M. Zhou, J. Han, X. Zhu, T. Dong, G. F. Gao, and P. Tien Generation of Murine CTL by a Hepatitis B Virus-Specific Peptide and Evaluation of the Adjuvant Effect of Heat Shock Protein Glycoprotein 96 and Its Terminal Fragments J. Immunol., January 1, 2005; 174(1): 195 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rivoltini, C. Castelli, M. Carrabba, V. Mazzaferro, L. Pilla, V. Huber, J. Coppa, G. Gallino, C. Scheibenbogen, P. Squarcina, et al. Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells J. Immunol., October 1, 2003; 171(7): 3467 - 3474. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Pratt and D. O. Toft Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery Experimental Biology and Medicine, February 1, 2003; 228(2): 111 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Baker-LePain, M. Sarzotti, T. A. Fields, C.-Y. Li, and C. V. Nicchitta GRP94 (gp96) and GRP94 N-Terminal Geldanamycin Binding Domain Elicit Tissue Nonrestricted Tumor Suppression J. Exp. Med., December 2, 2002; 196(11): 1447 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vogen, T. Gidalevitz, C. Biswas, B. B. Simen, E. Stein, F. Gulmen, and Y. Argon Radicicol-sensitive Peptide Binding to the N-terminal Portion of GRP94 J. Biol. Chem., October 18, 2002; 277(43): 40742 - 40750. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Sponaas, U. Zuegel, S. Weber, R. Hurwitz, R. Winter, S. Lamer, P. R. Jungblut, and S. H. E. Kaufmann Immunization with gp96 from Listeria monocytogenes-Infected Mice Is Due to N-Formylated Listerial Peptides J. Immunol., December 1, 2001; 167(11): 6480 - 6486. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Linderoth, M. N. Simon, J. F. Hainfeld, and S. Sastry Binding of Antigenic Peptide to the Endoplasmic Reticulum-resident Protein gp96/GRP94 Heat Shock Chaperone Occurs in Higher Order Complexes. ESSENTIAL ROLE OF SOME AROMATIC AMINO ACID RESIDUES IN THE PEPTIDE-BINDING SITE J. Biol. Chem., March 30, 2001; 276(14): 11049 - 11054. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |